September 30, 2020
YPrime Announces Optimized and Enhanced Capabilities with IRT 3.4 Release
Malvern, P.A., September 30, 2020 YPrime, a global leader of full-service end-to-end Interactive Response Technology (IRT) announces optimized and enhanced capabilities with its IRT 3.4 product release. YPrime project managers worked alongside clients to develop the roadmap for this release and incorporated their feedback to create a solution that enhances sponsor productivity and helps reduce timelines.
Offering even more configurable features, IRT 3.4 was designed to help streamline development by minimizing the need for the end-user to enlist the helpdesk, project manager or generate a change order. Some highlights from this update include:
- Revamped report architecture for study, site, and subject level reports. This enables higher quality, quicker implementation, protocol customizations, and faster load-times for site and sponsor users.
- Streamlined drug release status flow that is user-friendly; once that material list is approved, all kits will be moved to their respective areas for release.
- Enhanced subject management functionality provides a comprehensive data view, intuitive subject workflows, and one-click navigation.
- Improved code management solution that emphasizes code changes for visibility, review, and approval thus reducing change risk and streamlining deployments.
“This product release supports our best-in-class IRT solution that helps our clients streamline trial conduct and effectively manage their clinical supply chain,” remarked Mark Maietta, President at YPrime. “Our biostatisticians, project managers, and data managers provide their expertise throughout the study, to ensure our clients receive the full range of IRT support.”
YPrime’s technology solutions and domain expertise ensure statistical integrity upfront, reduce risk during your trial, and deliver submission-ready data at the end of every project.